Endovascular Therapy for Post-Thrombotic Syndrome (C-TRACT) @NEJMgroup
Endovascular Therapy for Post-Thrombotic Syndrome (C-TRACT)  @NEJMgroup
Uploaded April 2026 | Updated September 2026, 2 weeks ago
Among patients with moderate or severe PTS, the addition of endovascular therapy to standard care resulted in less severe PTS and better quality of life at 6 months than standard care alone but with a higher risk of bleeding.

Read the full phase 3 C-TRACT trial results and Research Summary at NEJM.org.

#surgery #cardiology #nejm
Endovascular Therapy for Post-Thrombotic Syndrome (C-TRACT)NEJM This Week — May 14, 2026Clinical Practice: Polymyalgia RheumaticaNEJM This Week — July 30, 2026Clement Lee, M.D., Playing Doctordle — August 12, 2026Azithromycin for Preschoolers with Wheezing in the ED (AZ-SWED)NEJM Interview: Amanda Banks on concerns about a potential association between GLP-1 receptor ago...Image Challenge | April 30, 2026NEJM This Week — August 20, 2026NEJM This Week — June 4, 2026Daraxonrasib in Metastatic Pancreatic Cancer (RASolute 302)Ask the Expert — Risk Prevention Tools for Cardiovascular Disease
NEJM Group |

Endovascular Therapy for Post-Thrombotic Syndrome (C-TRACT)

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER